The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medical Dry Powder Inhalers (DPIs) Market Research Report 2024

Global Medical Dry Powder Inhalers (DPIs) Market Research Report 2024

Publishing Date : Jun, 2023

License Type :

Report Code : 1742407

No of Pages : 91

Ask Your Query

Report Description
Table of Content

Synopsis
Global Medical Dry Powder Inhalers (DPIs) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Dry Powder Inhalers (DPIs) market research.

Key manufacturers engaged in the Medical Dry Powder Inhalers (DPIs) industry include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Medical Dry Powder Inhalers (DPIs) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medical Dry Powder Inhalers (DPIs) market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Dry Powder Inhalers (DPIs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura

Segment by Type

Single Dose
Multi Dose

Segment by Application

Asthma
COPD
Others

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Medical Dry Powder Inhalers (DPIs) report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Medical Dry Powder Inhalers (DPIs) Market Overview
1.1 Product Overview and Scope of Medical Dry Powder Inhalers (DPIs)
1.2 Medical Dry Powder Inhalers (DPIs) Segment by Type
1.2.1 Global Medical Dry Powder Inhalers (DPIs) Market Value Comparison by Type (2023-2029)
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Medical Dry Powder Inhalers (DPIs) Segment by Application
1.3.1 Global Medical Dry Powder Inhalers (DPIs) Market Value by Application: (2023-2029)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Medical Dry Powder Inhalers (DPIs) Market Size Estimates and Forecasts
1.4.1 Global Medical Dry Powder Inhalers (DPIs) Revenue 2018-2029
1.4.2 Global Medical Dry Powder Inhalers (DPIs) Sales 2018-2029
1.4.3 Global Medical Dry Powder Inhalers (DPIs) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Dry Powder Inhalers (DPIs) Market Competition by Manufacturers
2.1 Global Medical Dry Powder Inhalers (DPIs) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Dry Powder Inhalers (DPIs) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Manufacturers (2018-2023)
2.4 Global Medical Dry Powder Inhalers (DPIs) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Dry Powder Inhalers (DPIs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Dry Powder Inhalers (DPIs), Product Type & Application
2.7 Medical Dry Powder Inhalers (DPIs) Market Competitive Situation and Trends
2.7.1 Medical Dry Powder Inhalers (DPIs) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Dry Powder Inhalers (DPIs) Players Market Share by Revenue
2.7.3 Global Medical Dry Powder Inhalers (DPIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Dry Powder Inhalers (DPIs) Retrospective Market Scenario by Region
3.1 Global Medical Dry Powder Inhalers (DPIs) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Dry Powder Inhalers (DPIs) Global Medical Dry Powder Inhalers (DPIs) Sales by Region: 2018-2029
3.2.1 Global Medical Dry Powder Inhalers (DPIs) Sales by Region: 2018-2023
3.2.2 Global Medical Dry Powder Inhalers (DPIs) Sales by Region: 2024-2029
3.3 Global Medical Dry Powder Inhalers (DPIs) Global Medical Dry Powder Inhalers (DPIs) Revenue by Region: 2018-2029
3.3.1 Global Medical Dry Powder Inhalers (DPIs) Revenue by Region: 2018-2023
3.3.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Region: 2024-2029
3.4 North America Medical Dry Powder Inhalers (DPIs) Market Facts & Figures by Country
3.4.1 North America Medical Dry Powder Inhalers (DPIs) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Dry Powder Inhalers (DPIs) Sales by Country (2018-2029)
3.4.3 North America Medical Dry Powder Inhalers (DPIs) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Dry Powder Inhalers (DPIs) Market Facts & Figures by Country
3.5.1 Europe Medical Dry Powder Inhalers (DPIs) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Dry Powder Inhalers (DPIs) Sales by Country (2018-2029)
3.5.3 Europe Medical Dry Powder Inhalers (DPIs) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Dry Powder Inhalers (DPIs) Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Dry Powder Inhalers (DPIs) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Dry Powder Inhalers (DPIs) Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Dry Powder Inhalers (DPIs) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Dry Powder Inhalers (DPIs) Market Facts & Figures by Country
3.7.1 Latin America Medical Dry Powder Inhalers (DPIs) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Dry Powder Inhalers (DPIs) Sales by Country (2018-2029)
3.7.3 Latin America Medical Dry Powder Inhalers (DPIs) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Dry Powder Inhalers (DPIs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Dry Powder Inhalers (DPIs) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Dry Powder Inhalers (DPIs) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Dry Powder Inhalers (DPIs) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Dry Powder Inhalers (DPIs) Sales by Type (2018-2029)
4.1.1 Global Medical Dry Powder Inhalers (DPIs) Sales by Type (2018-2023)
4.1.2 Global Medical Dry Powder Inhalers (DPIs) Sales by Type (2024-2029)
4.1.3 Global Medical Dry Powder Inhalers (DPIs) Sales Market Share by Type (2018-2029)
4.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Type (2018-2029)
4.2.1 Global Medical Dry Powder Inhalers (DPIs) Revenue by Type (2018-2023)
4.2.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Type (2024-2029)
4.2.3 Global Medical Dry Powder Inhalers (DPIs) Revenue Market Share by Type (2018-2029)
4.3 Global Medical Dry Powder Inhalers (DPIs) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Dry Powder Inhalers (DPIs) Sales by Application (2018-2029)
5.1.1 Global Medical Dry Powder Inhalers (DPIs) Sales by Application (2018-2023)
5.1.2 Global Medical Dry Powder Inhalers (DPIs) Sales by Application (2024-2029)
5.1.3 Global Medical Dry Powder Inhalers (DPIs) Sales Market Share by Application (2018-2029)
5.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Application (2018-2029)
5.2.1 Global Medical Dry Powder Inhalers (DPIs) Revenue by Application (2018-2023)
5.2.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Application (2024-2029)
5.2.3 Global Medical Dry Powder Inhalers (DPIs) Revenue Market Share by Application (2018-2029)
5.3 Global Medical Dry Powder Inhalers (DPIs) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Corporation Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Chiesi Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cipla Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 3M Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.6.1 Hovione Corporation Information
6.6.2 Hovione Description and Business Overview
6.6.3 Hovione Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hovione Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Corporation Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mannkind Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mylan Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Corporation Information
6.11.2 Schering/Merck Medical Dry Powder Inhalers (DPIs) Description and Business Overview
6.11.3 Schering/Merck Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Schering/Merck Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Medical Dry Powder Inhalers (DPIs) Description and Business Overview
6.12.3 Teva Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teva Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Corporation Information
6.13.2 Vectura Medical Dry Powder Inhalers (DPIs) Description and Business Overview
6.13.3 Vectura Medical Dry Powder Inhalers (DPIs) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Vectura Medical Dry Powder Inhalers (DPIs) Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Dry Powder Inhalers (DPIs) Industry Chain Analysis
7.2 Medical Dry Powder Inhalers (DPIs) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Dry Powder Inhalers (DPIs) Production Mode & Process
7.4 Medical Dry Powder Inhalers (DPIs) Sales and Marketing
7.4.1 Medical Dry Powder Inhalers (DPIs) Sales Channels
7.4.2 Medical Dry Powder Inhalers (DPIs) Distributors
7.5 Medical Dry Powder Inhalers (DPIs) Customers
8 Medical Dry Powder Inhalers (DPIs) Market Dynamics
8.1 Medical Dry Powder Inhalers (DPIs) Industry Trends
8.2 Medical Dry Powder Inhalers (DPIs) Market Drivers
8.3 Medical Dry Powder Inhalers (DPIs) Market Challenges
8.4 Medical Dry Powder Inhalers (DPIs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}